Page 470 - Feline Cardiology
P. 470

Index  495


              Systemic hypertension, 325–338, 398  Systolic anterior motion (SAM) of the   Tadalafil, pulmonary arterial hypertension
                coexisting cardiac and renal problems   mitral valve, 6, 105            and, 390
                      and, 372                   anesthesia and, 415             Tapazole (methimazole), hyperthyroidism
                controlled, ocular manifestations of,   benign and pathologic murmurs caused   and, 403
                      327, 328                         by, 119                   Target organ damage, systemic
                defined, 325                     beta blocker therapy and, 156          hypertension and, 325–326, 338
                diagnostic testing, 334–336      degenerative valvular disease and,   TAT. See Thrombin-antithrombin
                  BP measurement, technique,           196–197                          complex
                      334–336                    differential diagnosis, HCM and, 121–122  Taurine, 434
                diagram of pathways involved in long-  drugs for, 434              deficiency of
                      term regulation of blood   echocardiographic identification of, 59  central retinal lesions and, 184, 185
                      pressure and abnormalities   familial human HCM cases and, 107  dilated cardiomyopathy and, 183,
                      related to development of, 330  HCM and, 116                      185
                differential diagnosis, 333–334    identification of, 134, 136–137  indications, dosage, available sizes, 461
                  for causes of, 334             mitral regurgitation and, 115     references for, 467
                  sphygmomanometer calibration,   murmur grades and, 119           supplementation, for cats with dilated
                      333–334                    visualizing, comprehensive             cardiomyopathy, 186
                  white coat effect, 333               echocardiogram and, 280     whole blood concentrations,
                  wrong cuff location-too proximal, 333  Systolic blood pressure, measuring, in cats   myocardial failure and, 282
                  wrong cuff size, 333                 with left ventricular     TDI, noninvasive assessment of diastolic
                drugs for, 436                         hypertrophy, 152, 334–336        function and, 139
                etiology, pathophysiology, and gross   Systolic clicks, 11       TDI. See Tissue Doppler imaging
                      pathology, 329–330        Systolic dysfunction. See also Dilated   TEG. See Thromboelastography
                follow-up and, 337                     cardiomyopathy            Telazol (tiletamine-zolazepam)
                fundus after treatment with amlodipine   echocardiographic evaluation of, 58  anesthesia, for cardiac patient, 414t,
                      besylate and benazepril    HCM and, 141                           417
                      hydrochloride, 328        Systolic function, increased,      anesthetizing fractious cats with, 418
                fundus photograph of geriatric cat     hyperthyroidism and, 398  Telemetric (wireless) monitoring,
                      with, 326                 Systolic heart failure, 263–264         electrocardiography and, 80
                gross pathologic specimens from cats   Systolic murmurs, 7, 119  Telemetry, forms of, for cats, 80
                      with, 328                 Systolic myocardial velocity, reduced,   Temperature, heartworm transmission
                  subacute encephalopathy due to, 329  HCM and, 142                     and, 354
                history and chief complaint, 331–332  Systolic myocardial failure, 257–258  arterial thromboembolism and low
                  incidental finding of hypertension or   anesthesia in patient with cardiac   body, 308, 320
                      hypertension-associated          disease and, 416–417      Tenormin (atenolol), 461
                      abnormality, 332           anesthetic management and, 413    indications, dosage, available sizes, 462
                  overt manifestations of systemic   characteristics of, 263     Terbutaline, 444
                      hypertensive decompensation,   Systolic performance indices, normal   asthma and, 375
                      331–332                          feline, echocardiographically   heartworm disease and, 360
                hypotension-promoting vs.              derived, 60t, inside covers  indications, dosage, available sizes, 462
                      hypertension-promoting    Systolic arterial blood pressure, normal, in   second-degree AV block and, 238
                      mechanisms and, 330              cats, 387                 Tetralogy of Fallot, 85, 99
                monitoring, 338                 Systolic time intervals, normal values,   Theo-Dur (theophylline sustained-
                outcome and prognosis, 338             feline, inside covers            release), asthma and, 376
                physical examination, 332–333   Systolic ventricular wall deformation,   Theophylline
                prevalence of, 327–328                 HCM and rate of, 142        asthma and, 376
                  in hyperthyroid cats, 396                                        heartworm disease and, 360
                signalment, 331                 T                                  sinus bradycardia and, 219
                target organ damage and, 325–326  Tachyarrhythmias, 124, 166, 213  Thiazides, 373
                  reducing risk of, 338         Tachycardia, 213, 214            Thiopental, 416
                treatment, 336–338, 436          anesthetic risk and, 412        Third-degree atrioventricular (AV) block,
                  general, 336–338               HCM and, 119–120                       124, 237, 238–241
                  hypertensive crisis, 338       profound, syncope and, 15         causes of, 240
                untreated, ocular manifestations of, 327  stress-induced, atenolol and, 157  chief complaints with, 240
                “white coat” hypertension vs., 281  Tachypnea                      pacemaker implantation and, 240
              Systemic hypertensive decompensation,   arterial thromboembolism and, 308  in two cats, 239
                      overt manifestations of,   cardiac tumors and, 202         Third heart sound (S 3), gallop sounds
                      331–332                    congestive heart failure and, 268      and, 10, 11
              Systemic vascular resistance, normal   lower airway disease and, 25  Thoracic radiography
                      values, feline, inside covers  pleural effusion and, 20      arrhythmias and, 215
   465   466   467   468   469   470   471   472   473